Aclara BioSciences, a US developer of lab-on-a-chip technology
that was ordered to pay rival company Caliper Technologies $52
million over the disclosure of trade secrets, has succeeded in
persuading a court to reduce the damages to reflect a $12 million
settlement from another related case and reduced by $5 million the
sum awarded by a jury making its final award a total of $47
million.23 Nov 2000